Sex hormone‐binding globulin as a marker for the thrombotic risk of hormonal contraceptives
@article{Raps2012SexHG, title={Sex hormone‐binding globulin as a marker for the thrombotic risk of hormonal contraceptives}, author={M. Raps and F. Helmerhorst and K. Fleischer and S. Thomassen and F. Rosendaal and J. Rosing and B. Ballieux and H. van Vliet}, journal={Journal of Thrombosis and Haemostasis}, year={2012}, volume={10} }
Summary. Background: It takes many years to obtain reliable values for the risk of venous thrombosis of hormonal contraceptive users from clinical data. Measurement of activated protein C (APC) resistance via thrombin generation is a validated test for determining the thrombogenicity of hormonal contraceptives. Sex hormone‐binding globulin (SHBG) might serve as a marker for the risk of venous thrombosis, and can be easily and rapidly measured in routine laboratories.
Topics from this paper
61 Citations
Sex hormone‐binding globulin as a marker for the thrombotic risk of hormonal contraceptives: a rebuttal
- Medicine
- Journal of thrombosis and haemostasis : JTH
- 2013
- 8
Sex hormone‐binding globulin levels are not causally related to venous thrombosis risk in women not using hormonal contraceptives
- Medicine
- Journal of thrombosis and haemostasis : JTH
- 2012
- 21
Sex hormone-binding globulin and thrombin generation in women using hormonal contraception
- Medicine
- Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals
- 2017
- 5
- Highly Influenced
Thyroid function, activated protein C resistance and the risk of venous thrombosis in users of hormonal contraceptives.
- Medicine
- Thrombosis research
- 2014
- 11
Oral Contraceptives and HRT Risk of Thrombosis
- Medicine
- Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis
- 2018
- 15
- Highly Influenced
Endogenous sex hormones and risk of venous thromboembolism in young women
- Medicine
- Journal of thrombosis and haemostasis : JTH
- 2019
- 4
The effect of different hormonal contraceptives on plasma levels of free protein S and free TFPI.
- Medicine
- Thrombosis and haemostasis
- 2013
- 22
- PDF
Epidemiology of hormonal contraceptives-related venous thromboembolism.
- Medicine
- European journal of endocrinology
- 2014
- 47
- PDF
References
SHOWING 1-10 OF 45 REFERENCES
Can changes in sex hormone binding globulin predict the risk of venous thromboembolism with combined oral contraceptive pills?
- Medicine
- Acta obstetricia et gynecologica Scandinavica
- 2002
- 142
Sex hormone-binding globulin: not a surrogate marker for venous thromboembolism in women using oral contraceptives.
- Medicine
- Contraception
- 2008
- 16
Sex hormone--binding globulin--a surrogate marker for the prothrombotic effects of combined oral contraceptives.
- Medicine
- 2004
- 22
Prothrombotic changes in users of combined oral contraceptives containing drospirenone and cyproterone acetate
- Medicine
- Journal of thrombosis and haemostasis : JTH
- 2004
- 46
Effects of Oral and Transdermal Hormonal Contraception on Vascular Risk Markers: A Randomized Controlled Trial
- Medicine
- Obstetrics and gynecology
- 2008
- 66
The venous thrombotic risk of oral contraceptives, effects of oestrogen dose and progestogen type: results of the MEGA case-control study
- Medicine
- BMJ : British Medical Journal
- 2009
- 375
- PDF
Activated protein C resistance determined with a thrombin generation‐based test predicts for venous thrombosis in men and women
- Medicine
- British journal of haematology
- 2003
- 130
The effect of the levonorgestrel-releasing intrauterine system on the resistance to activated protein C (APC).
- Medicine
- Thrombosis and haemostasis
- 2009
- 23
Hormone therapies and venous thromboembolism: where are we now?
- Medicine
- Journal of thrombosis and haemostasis : JTH
- 2011
- 54
- PDF